cannabidiol cbd kænəbəˈdaɪəl phytocannabinoid discovered one identified cannabinoids cannabis plants along tetrahydrocannabinol thc accounts plants clinical research cbd included studies related anxiety cognition movement disorders pain insufficient highquality evidence cannabidiol effective nevertheless cbd herbal dietary supplement promoted unproven claims particular therapeutic cannabidiol taken internally multiple ways including inhaling cannabis smoke vapor oral aerosol spray may supplied cbd oil containing cbd active ingredient excluding thc terpenes cbddominant hemp extract oil capsules dried cannabis prescription liquid cbd psychoactivity modulate psychoactive effects thc body cbd heated may partially converted mechanism action biological effects unlike thc acts cannabinoid receptor type partial agonist cbd instead negative allosteric modulator united states cannabidiol drug epidiolex approved food drug administration fda treatment two epilepsy united states farm bill removed hemp hemp extracts including cbd controlled substances act marketing sale cbd formulations medical use ingredient dietary supplements manufactured foods remains illegal fda regulation cannabidiol generic name drug inntooltip international nonproprietary limited highquality evidence cannabidiol neurological effect united states federal illegality made difficult historically conduct research united states fda indicated one brand prescription cannabidiol called epidiolex treatment seizures associated dravet syndrome syndrome tuberous sclerosis complex people one year age epidiolex treatment generally well tolerated associated minor adverse effects gastrointestinal upset decreased appetite lethargy sleepiness poor sleep european union cannabidiol epidyolex indicated use adjunctive therapy seizures associated syndrome dravet syndrome conjunction clobazam people two years age label epidiolex us expanded include seizures associated tuberous sclerosis complex epidiolexepidyolex first prescription formulation plantderived cannabidiol approved regulatory bodies us research uses cannabidiol includes several neurological disorders findings confirmed establish uses clinical october fda issued advisory warning effects cbd pregnancy breastfeeding unknown indicating safety doses interactions drugs foods side effects cbd clinically defined may pose risk mother many claims made therapeutic benefit cannabidiol backed sound evidence claims treatment cancer label epidiolex us expanded include treatment seizures associated tuberous acclaimed relieving chronic pain researchers conclude evidence insufficient determine effectiveness cbd pain relief primarily due challenging access pure cannabidiol appear intoxicating caused cannabis preliminary research possible antianxiety antipsychotic legal landscape understanding differences medical cannabinoids unfolds experts working distinguish medical cannabis varying degrees psychotropic effects deficits executive function medical cbd therapies would commonly present reduced nonpsychoactive sideeffect various strains medical cannabis found significant variation ratios cbdtothc known contain nonpsychotropic psychoactive cannabis regardless cbd content derived flower bud genus cannabis defined us federal law nonpsychoactive hemp also commonly termed industrial hemp regardless cbd content part cannabis plant whether growing containing concentration dryweight certain standards required legal growing cultivating producing hemp plant federal standards quality enforced hemp industry certain state regulations place vary state instance colorado industrial hemp program registers growers industrial hemp samples crops verify dryweight thc concentration exceed research indicates cannabidiol may reduce adverse effects thc particularly causing intoxication sedation high safety studies cannabidiol showed well tolerated may cause tiredness somnolence sedation diarrhea changes appetite common adverse effects common somnolence sedation side effects cbd dose epidiolex documentation lists sleepiness insomnia poor quality sleep decreased appetite diarrhea november fda issued concerns safety cannabidiol stating cbd use potential cause liver injury interfere mechanisms prescription drugs produce gastrointestinal disorders affect alertness fda updated safety concerns acknowledging unknown effects protracted use affects developing brain fetus infants breastfeeding whether interacts dietary supplements prescription drugs whether male fertility affected possible side effects september people contacted us poison control centers cbdinduced illnesses doubling number cases rate increasing times case numbers cases reported received medical attention people admitted hospital intensive care unit possibly due exposure products drug interactions fda stated scientific studies show possible harm male reproductive system including testicular atrophy harm liver interactions certain medications fda found adequate information showing much cbd consumed long causing harm particularly true vulnerable populations like children laboratory evidence indicated cannabidiol may reduce thc clearance increasing plasma concentrations may raise thc availability receptors enhance effect dosedependent vitro cannabidiol inhibited activity voltagedependent sodium potassium channels may affect neural recent study using xray crystallography showed cbd binds inside sodium channel pore novel site interface fenestrations central hydrophobic cavity channel binding site blocks transmembranespanning sodium ion translocation pathway providing molecular mechanism channel inhibition could contribute reduced small clinical trial reported cbd partially inhibited hydroxylation thc little known potential drug interactions cbd mediates decrease clobazam work human liver microsomes shows cannabidiol inhibits number research projects scientific publications cannabidiol cannabinoids pets surged late nonetheless december hempderived cannabinoidrich registered veterinary medicinal products major regions see legal status us territories however numerous veterinary nutraceutical products available counter otc lack clarity regulations governing veterinary hemp food supplements allows products questionable quality flood may pose risk wellbeing pets owners understand better benefits cbd associated compounds quality life animals companies specialized cbd products animals funding research cbds ability help regulate endocannabinoid reduce release excitatory neurotransmitters could result retrograde inhibitory signal lessens chronic pain responses studies dogs chronic pain associated osteoarthritis showed increase level activity animals receiving cbdrich food results seen humans drugs epidiolex sativex scientific studies could expected cbdbased products would helpful manage seizures dogs however despite numerous case reports presented veterinary neurologists supporting benefits cbd adjunctive therapy december published controlled studies shown statistically significant decrease number seizures across groups receiving oral bioavailability cbd varies greatly across species linked presentation time kinetic examination dogs showed absorption cannabidiolic acid cbda occur molecule absorbed least twice well cbd post oral found major metabolites cbd humans prevalent dogs found primary metabolite dogs receiving cbdenriched cannabisderived herbal suggesting canine human cbd metabolic route might somewhat cannabidiol low affinity cannabinoid although acts antagonist agonists despite low affinity core effect antagonism receptors reduced binding affinity thc related cannabidiol may antagonist g proteincoupled receptor putative cannabinoid receptor expressed caudate nucleus putamen also may act inverse agonist cbd shown act serotonin receptor partial higher concentrations cbd acts inverse agonist allosteric modulator μ δopioid receptors pharmacological effects cbd may involve pparγ agonism inhibition voltagegated cation channels intracellular calcium oral bioavailability cannabidiol approximately humans bioavailability via inhalation mean elimination halflife cbd cannabidiol metabolized liver well intestines cytochrome enzymes isoenzymes forming variety metabolites well isomers derivatives hydroxylated alkyl side chain followed facilitates decarbonylation cbd liberate carbon monoxide bioactive gasotransmitter pharmaceutical cbd may wide margin nabiximols brand name sativex oromucosal spray made complex botanical mixture containing cannabidiol cbd thc additional cannabinoid noncannabinoid constituents cannabis sativa plants approved health canada treat central neuropathic pain multiple sclerosis cancerrelated new zealand sativex approved use addon treatment symptom improvement people moderate severe spasticity due multiple sclerosis responded adequately antispasticity epidiolex orally administered cannabidiol solution approved us food drug administration treatment two rare forms childhood epilepsy syndrome dravet seizures associated tuberous sclerosis us approved indications patients one year age older room temperature cannabidiol colorless crystalline strongly basic media presence air oxidized acidic conditions cyclizes also occurs synthesis cannabidiol accomplished several research cannabis produces cbdcarboxylic acid metabolic pathway thc next last step cbda synthase performs catalysis instead thca typical operating temperature range ecigarettes cbd transformed chemical substances cannabinol cannabichromene predominant pyrolysates chemical point view cbd ecigarettes considered precursor studies conducted fda determined majority cbd products accurately labeled amount cbd example analysis cannabidiol content oil tincture liquid vape products purchased online united states showed mislabeled higher lower content stated product fda conducted study cbd products found half contained november fda issued dozens warning letters american manufacturers cbd products false advertising illegal interstate marketing cbd unapproved drug treat diseases cancer osteoarthritis symptoms opioid withdrawal alzheimers disease pet chemical analysis cbd products found many contain levels cbd claimed december federal trade commission initiated law enforcement crackdown american companies marketing cbd products unapproved warning also applied hemp cbd capsules oil marketed illegally adhering federal definition dietary efforts isolate active ingredients cannabis made cannabidiol studied minnesota wild egyptian cannabis indica chemical formula cbd proposed method isolating wild structure stereochemistry determined selective breeding cannabis plants expanded diversified commercial therapeutic markets develop growers us succeeded lowering proportion cbdtothc accommodate customers preferred varietals mindaltering due higher thc lower cbd us hemp classified federal government cannabis containing thc dry weight classification established farm bill refined include hempsourced extracts cannabinoids derivatives definition food beverage products containing cannabidiol widely marketed united states early hemp seed ingredients naturally contain thc cbd may contaminated trace amounts outside harvesting declared us food drug administration generally recognized safe gras december cbd declared gras us federal law illegal sell food dietary supplement animal state laws vary considerably nonmedical cannabis derived products legalized jurisdictions similar energy drinks protein bars may contain vitamin herbal additives food beverage items infused cbd alternative means ingesting substance united states numerous products marketed containing cbd reality contain little companies marketing cbdinfused food products claims similar effects prescription drugs received warning letters fda making unsubstantiated health february new york city department health announced plans fine restaurants sell food drinks containing cbd beginning october cannabidiol used professional amateur athletes across disciplines countries world antidoping agency removing cbd banned substances list united states antidoping agency united kingdomantidoping agency anticbd policies latter stating cbd currently listed world antidoping agency prohibited list result permitted use sport though intended benefits unclear backed clinical evidence cannabinoids including limited cannabis hashish marijuana thc prohibited incompetition intention regulations prohibit cannabinoids activate receptors brain activated cannabis manufacturer canopy growth acquired majority ownership biosteel sports nutrition developing cbd products endorsement numerous professional national hockey league alumni association began project canopy growth determine cbd cannabis products might improve neurological symptoms quality life headinjured sports leagues announced sponsorships cbd companies major league baseball charlottes web ultimate fighting championship love numerous professional athletes use cbd primarily treating prescription medicine schedule therapeutic use containing two percent less cannabinoids commonly found cannabis schedule drug susmp prescription medicine prescription animal remedy substances use supply order persons permitted state territory legislation prescribe available pharmacist june australian therapeutic goods administration tga published consultation proposal pave way make low dose cbd available consumerpatients via pharmacists moving products schedule products sold would need safety quality efficacy preassessed tga formally approved sale details outlined tga would made available maximum daily dose mgday thc finished product allowed maximum supply plantderived synthetic proposal based initial literature review safety low dose cbd published tga april epidyolex approved adjunctive therapy seizures associated syndrome dravet syndrome september bulgaria became first country european union allow retail sales food products supplements containing cbd despite ongoing discussion within eu classification cbd novel however exists legal gap lack legallypermissible minimum amount thc products containing october cannabidiol became legal recreational medical use federal cannabis august cbd products canada could sold authorized retailers federally licensed medical companies limiting access general nonetheless online delivery services authorized cannabis retail stores october accessibility steadily increased canadian government states cbd products subject rules requirements apply cannabis cannabis act requires processing licence manufacture products containing cbd sale matter source cbd cbd products containing cbd cannabis oil may sold authorized retailer licensed seller medical edible cbd products scheduled permitted sale canada october human august still illegal carry cannabis cannabisderived products including products containing cbd across canadian border one carries amount cannabis purpose including medical needs declared canada border services agency declaring serious criminal may state agricultural food inspection czech republic putting together broad regulations regarding ban cbd make illegal sell products containing cannabidiol cannabinoids derived hemp result eu novel food regulation case czech republic european industrial hemp association submitted official request czech republic recognize natural hemp extracts cannabinoids traditional european commission announced cbd cannabinoids would classified novel meaning cbd products would require authorization eu novel food regulation stating product used food food ingredient may may placed market eu food food ingredient safety assessment novel food regulation recommendation applying cbd extracts synthesized cbd cbd products including cbd oil scheduled final ruling european commission march approved manufacturers cbd products would required conduct safety tests prove safe consumption indicating cbd products would eligible legal commerce least december european commission concluded cbd considered drug qualified cannabidiol listed eu cosmetics ingredient database however listing ingredient assigned inci name cosing mean used cosmetic products approved several industrial hemp varieties legally cultivated western europe variety fedora cannabinoid profile consistently around thc less hksar government proposed ban use cannabidiol including academic research medical professionals within hong kong territory making hong kong first jurisdiction world complete prohibition cannabidiol starting february part due possible presence thc illegal hong kong according research subsidized hong kong sar new zealand government made changes regulations restrictions would removed meant doctor able prescribe cannabidiol passing misuse drugs medicinal cannabis amendment act december means cannabidiol longer controlled drug new zealand prescription medicine medicines act restriction tetrahydrocannabinols thcs specified substances within product must exceed percent total cbd tetrahydrocannabinol thc specified according document received response appeal ministry internal affairs russian federation measures state control russian federation regarding cbd established however also response ministry health russian federation indicating cbd considered isomer restricted thc isomer argument nonetheless vague progesterone freely sold pharmacies also isomer thc three february deputy moscow city duma darya besedina sent official request prime minister russian federation mikhail mishustin request eliminate legal ambiguity publishing official explanations necessary making required changes corresponding government singapore allows medical cannabis casebycase basis usually last resort drug case evaluated government largely comes form cannabidiol however country flexible required patient treatment despite strictest drug laws world cannabidiol classified medical product however july supreme court sweden ruled cbd oil concentration thc falls narcotic control thc remains illegal cannabidiol subject swiss narcotic acts produce comparable psychoactive cannabis products containing less thc sold purchased april ukrainian government legalised use isolated cannabidiol additionally approved nabiximols cannabidiolcontaining drug medical cannabidiol oralmucosal spray formulation combined product available prescription relief severe spasticity due multiple sclerosis antispasmodics effective united products containing cannabidiol marketed medical purposes classed medicines uk regulatory body medicines healthcare products regulatory agency mhra could marketed without regulatory approval medical cannabis oil legal possess buy sell uk providing product contain milligram thc advertised providing medicinal individual police officers others illinformed exact legislature pertaining cannabidiol however may erroneously consider dubious legality reflecting lack january uk food standards agency indicated would regard cbd products including cbd oil novel food history use may stated products must authorisation proven safety deadline companies existing products submit full validated novel foods application fsa march failure date would exclude companies selling new products containing cbd deadline would require fully approved february uk fsa advised vulnerable people pregnant women breastfeeding mothers already taking medication medical concerns take cbd fsa recommended healthy adults consume mg cbd per cannabidiol scheduled single convention narcotic drugs cannabis international narcotics control board reminds member states reconvened sixtythird session commission narcotic drugs december states members commission rejected recommendation footnote added entry cannabis cannabis resin schedule convention amended exempt international control preparations containing predominantly cbd per cent cannabidiol extracted marijuana remains schedule controlled approved prescription drug dietary supplement allowed interstate commerce united cbd derived hemp thc lower legal sell cosmetics ingredient purposes regulated fda sold federal law ingredient food dietary supplement animal common misconception legal ability sell hemp may contain cbd hemp extracts derivatives including cbd makes cbd legal sale supplement september gw pharmaceuticals drug epidiolex placed schedule v controlled substances act drug enforcement administration following approval fda rare types childhood removed controlled substances act dea april epidiolex available prescription use cnn program featured charlottes web cannabis brought increased attention use cbd treatment seizure disorders number states passed laws next years allow use lowthc highcbd cannabis oil states addition states already legalized cannabis medical recreational many states relaxed laws regarding cbd following passage farm farm legalized sale nonviable hemp material grown within states participating hemp pilot program defined hemp cannabis containing less farm bill removed hemp plant derivatives extracts cannabinoids isomers acids salts salts isomers whether growing tetrahydrocannabinol concentration percent dry weight basis including cbd controlled substances act making legal manufacture united fda retains regulatory authority hempderived dea involved regulation legallycompliant hemp hemp farm bill requires research development cbd therapeutic purpose would conducted notification reporting httpsenwikipediaorgwikicannabidiol